Annual Accounts Payable
$491.80 K
-$4.65 M-90.44%
December 1, 2023
Summary
- As of February 7, 2025, CYTO annual accounts payable is $491.80 thousand, with the most recent change of -$4.65 million (-90.44%) on December 1, 2023.
- During the last 3 years, CYTO annual accounts payable has fallen by -$334.90 thousand (-40.51%).
- CYTO annual accounts payable is now -90.44% below its all-time high of $5.14 million, reached on December 31, 2022.
Performance
CYTO Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$526.60 K
+$136.60 K+35.03%
June 1, 2024
Summary
- As of February 7, 2025, CYTO quarterly accounts payable is $526.60 thousand, with the most recent change of +$136.60 thousand (+35.03%) on June 1, 2024.
- Over the past year, CYTO quarterly accounts payable has dropped by -$1.66 million (-75.89%).
- CYTO quarterly accounts payable is now -89.76% below its all-time high of $5.14 million, reached on December 31, 2022.
Performance
CYTO Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
CYTO Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -90.4% | -75.9% |
| 3 y3 years | -40.5% | -89.8% |
| 5 y5 years | -73.3% | -89.8% |
CYTO Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -90.4% | at low | -89.8% | +35.0% |
| 5 y | 5-year | -90.4% | at low | -89.8% | +35.0% |
| alltime | all time | -90.4% | +218.1% | -89.8% | +35.0% |
Altamira Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | $526.60 K(+35.0%) |
| Dec 2023 | $491.80 K(-90.4%) | $390.00 K(-82.1%) |
| Jun 2023 | - | $2.18 M(-57.5%) |
| Dec 2022 | $5.14 M(+32.6%) | $5.14 M(+55.1%) |
| Jun 2022 | - | $3.32 M(-14.5%) |
| Dec 2021 | $3.88 M(+369.0%) | $3.88 M(+141.9%) |
| Jun 2021 | - | $1.60 M(+93.9%) |
| Dec 2020 | $826.70 K(-11.6%) | $826.70 K(-37.4%) |
| Jun 2020 | - | $1.32 M(+41.2%) |
| Dec 2019 | $935.60 K(-49.1%) | $935.60 K(+9.2%) |
| Jun 2019 | - | $857.10 K(-53.4%) |
| Dec 2018 | $1.84 M(+73.5%) | $1.84 M(+61.8%) |
| Sep 2018 | - | $1.14 M(-50.2%) |
| Jun 2018 | - | $2.28 M(+60.4%) |
| Mar 2018 | - | $1.42 M(+34.1%) |
| Dec 2017 | $1.06 M | $1.06 M(-10.2%) |
| Sep 2017 | - | $1.18 M(-4.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2017 | - | $1.23 M(-41.1%) |
| Mar 2017 | - | $2.09 M(+23.0%) |
| Dec 2016 | $1.70 M(+74.4%) | $1.70 M(+1.9%) |
| Sep 2016 | - | $1.67 M(+147.8%) |
| Jun 2016 | - | $674.00 K(-46.1%) |
| Mar 2016 | - | $1.25 M(+28.1%) |
| Dec 2015 | $976.80 K(-69.3%) | $976.80 K(-66.4%) |
| Sep 2015 | - | $2.91 M(+27.6%) |
| Jun 2015 | - | $2.28 M(-29.1%) |
| Mar 2015 | - | $3.21 M(+1.0%) |
| Dec 2014 | $3.18 M(+197.9%) | $3.18 M(-16.4%) |
| Sep 2014 | - | $3.80 M(+206.3%) |
| Jun 2014 | - | $1.24 M(+11.2%) |
| Mar 2014 | - | $1.12 M(+4.6%) |
| Dec 2013 | $1.07 M(+137.4%) | $1.07 M |
| Dec 2012 | $449.20 K(+190.6%) | - |
| Dec 2011 | $154.60 K | - |
FAQ
- What is Altamira Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Altamira Therapeutics?
- What is Altamira Therapeutics annual accounts payable year-on-year change?
- What is Altamira Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Altamira Therapeutics?
- What is Altamira Therapeutics quarterly accounts payable year-on-year change?
What is Altamira Therapeutics annual accounts payable?
The current annual accounts payable of CYTO is $491.80 K
What is the all time high annual accounts payable for Altamira Therapeutics?
Altamira Therapeutics all-time high annual accounts payable is $5.14 M
What is Altamira Therapeutics annual accounts payable year-on-year change?
Over the past year, CYTO annual accounts payable has changed by -$4.65 M (-90.44%)
What is Altamira Therapeutics quarterly accounts payable?
The current quarterly accounts payable of CYTO is $526.60 K
What is the all time high quarterly accounts payable for Altamira Therapeutics?
Altamira Therapeutics all-time high quarterly accounts payable is $5.14 M
What is Altamira Therapeutics quarterly accounts payable year-on-year change?
Over the past year, CYTO quarterly accounts payable has changed by -$1.66 M (-75.89%)